FDA clears a Myoscience 510(k) for its iovera device for relieving pain and symptoms associated with osteoarthritis of the knee for up to 90 days.
Federal Register notice: FDA extends the comment period until 7/18 on a final rule that clarifies for drug and device manufacturers the agencys interp...
AdvaMed praises legislation to allow some low- and moderate-risk Class 2 medical devices to be cleared based on objective criteria without having to b...
The House Energy and Commerce Subcommittee on Health advances the FDA Reauthorization Act that would reauthorize user fee programs for five years begi...
CDERs John Whyte says a 6/15 symposium will look at ways to reduce preventable medication errors.
HHS secretary Tom Price calls on Congress to make all FDA medical product review activities 100% user fee supported.
FDA says some Magellan Diagnostics lead tests could yield inaccurate results when used with blood drawn from a vein.
Researchers find that adults are more aware of FDA than adolescents, but adolescents trust the agency more than adults do.